Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Meds Catalog

Sucralfate

Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.

Both Catalog partial Not FDA-approved for animals Multiple FDA labelers Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Storefront facts
Catalog refreshed
May 5, 2026, 10:05 a.m.

Roxee has a partial storefront projection for this medication. Some primary facts still need verification.

FDA applications
FDA application data refreshed
May 5, 2026, 10:00 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
May 5, 2026, 10:01 a.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Storefront facts: Source Roxee | Refreshed May 5, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC

Evidence

Reviewed / Updated / Sources

Reviewed by: Not available

Last reviewed: April 15, 2026

Updated: April 15, 2026, 10:04 AM UTC

Sources:
Image coming soon
Sucralfate

Sucralfate

Drug type: Generic ingredient • Branded profile • Not FDA-approved for animals

Both 81% storefront ready

Species: Both

Approval status: Not FDA-approved as an animal drug. No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Sucralfate

Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus. Species commonly shown: Both.

Generic name
Sucralfate
Brand names
Sucralfate
Manufacturer
Multiple FDA labelers
Species
Both
Completeness
81%
Validation
Incomplete
Brand names
Sucralfate

Indications / Uses

Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus.

Side Effects

Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anorexia, Death by euthanasia, Elevated alanine aminotransferase (ALT).

FAQ

Both

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Roxee still has limited plain-language guidance for this medication. Use the official documents and your veterinarian's instructions for product-specific details.

Used for:

Your vet decides this. Here's what owners typically ask/watch for.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Death (1 reports)
  • Cough (1 reports)
  • Constipation (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Major cautions & emergency warning signs

Side effects to monitor:

  • Death
  • Cough
  • Constipation

Most reported reactions:

  • Death (1 reports)
  • Cough (1 reports)
  • Constipation (1 reports)

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA labelers
Identifiers:
NDC Package: 31260-402-01 NDC Package: 31260-402-02 NDC Package: 73377-001-01 NDC Package: 73377-001-02 NDC Package: 73377-001-03 NDC Package: 73377-001-04 NDC Product: 31260 NDC Product: 73377

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
29
Species represented
2
Grouped by Body System
Digestive (3) · Loss of appetite, Bloody diarrhoea, Blood in vomit Behavior (1) · Behavioral disorder (unspecified) Other (28) · Death, Cough, Constipation
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Other 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1

Species coverage: Dog (17) Cat (15)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Digestive Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Digestive Cat Serious - 1
Digestive Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Behavior Dog Serious - 1
Other Dog Non-serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Non-serious - 1
Source metadata:

Documents

Owner handouts and official technical documents open on-page first, with the original source still one click away.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

2

FOI

0
No FOI links yet.

SUCRALFATE SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for SUCRALFATE. Use the source link for the full official labeling record.

Sucralfate SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Sucralfate. Use the source link for the full official labeling record.
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Storefront facts: Source Roxee | Refreshed May 5, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: SUCRALFATE Sucralfate
Manufacturer mapping: Multiple FDA labelers
Case-reported brands (openFDA): MSK
Catalog species: Both
NDC: Packages 31260-402-01 31260-402-02 73377-001-01 73377-001-02 73377-001-03 73377-001-04 • Products 31260 73377
Safety (openFDA)
Top reactions: Dog 83 • Cat 59 • View
Case summaries: 14 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Top reaction signals
Death (1) Cough (1) Constipation (1) Conjunctivitis (1) Confusion (1) Collapse NOS (1) Cardiac enlargement (1) Bumps on skin (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NDC Package: 31260-402-01 NDC Package: 31260-402-02 NDC Package: 73377-001-01 NDC Package: 73377-001-02 NDC Package: 73377-001-03 NDC Package: 73377-001-04 NDC Product: 31260 NDC Product: 73377
Package NDC Product NDC Form / Route Status
31260-402-01 31260 -
31260-402-02 31260 -
73377-001-01 73377 -
73377-001-02 73377 -
73377-001-03 73377 -
73377-001-04 73377 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • SUCRALFATE SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Sucralfate SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 29 Clinical 7 Manufacturer 0 Marketing 0
Current Field Facts
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-21)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-20)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-19)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-17)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anorexia, Death by euthanasia, … (Clinical, 2026-04-11)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-05-05)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-05-03)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-05-02)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-04-29)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-04-28)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-04-27)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-04-26)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-04-25)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-04-22)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anorexia, Death by euthanasia, … (Official, 2026-05-05)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anorexia, Death by euthanasia, … (Official, 2026-05-03)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anorexia, Death by euthanasia, … (Official, 2026-04-30)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anorexia, Death by euthanasia, … (Official, 2026-04-29)
Recent Revisions
  • side_effects updated 2026-05-05 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-05-03 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-29 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-28 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-27 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-26 10:06 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-25 10:05 by etl_backfill • Backfilled from existing medication fields
  • monitoring updated 2026-04-21 10:07 by curated_loader • Clinical monitoring context for feline diabetes management.
  • usage updated 2026-04-21 10:07 by curated_loader • Usage statement from FDA warning letter and approved-product context.
  • drug_profile_type updated 2026-04-21 10:07 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
  • manufacturer_name updated 2026-04-21 10:07 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
  • brand_names updated 2026-04-21 10:07 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
  • approval_reference updated 2026-04-21 10:07 by curated_loader • Official FDA application reference for Senvelgo.
  • monitoring updated 2026-04-20 10:08 by curated_loader • Clinical monitoring context for feline diabetes management.
  • usage updated 2026-04-20 10:08 by curated_loader • Usage statement from FDA warning letter and approved-product context.
  • drug_profile_type updated 2026-04-20 10:08 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
  • manufacturer_name updated 2026-04-20 10:08 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
  • brand_names updated 2026-04-20 10:08 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
  • approval_reference updated 2026-04-20 10:08 by curated_loader • Official FDA application reference for Senvelgo.

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published

Data source: FDA Animal Drugs @ FDA (public search export).

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Dog Bloody diarrhoea (1) • Cat Blood in vomit (1) • Cat

Showing top 5 for Digestive.

Behavior
Behavioral disorder (1) • Dog

Showing top 5 for Behavior.

Other
Death (1) • Dog Cough (1) • Dog Constipation (1) • Cat Conjunctivitis (1) • Dog Confusion (1) • Dog
Show more (23)
Collapse NOS (1) • Dog Cardiac enlargement (1) • Cat Bumps on skin (1) • Dog Bradycardia (1) • Cat Bloody stool (1) • Cat Blood in urine (1) • Cat Blood clot (1) • Cat Bladder distension (1) • Cat Bilirubinuria (1) • Cat Bacterial skin infection NOS (1) • Dog Azotaemia (1) • Cat Arched back (1) • Dog Angioedema (1) • Dog Anaphylaxis (1) • Cat Anaemia NOS (1) • Dog Agglutination test, positive (1) • Dog Accidental exposure (1) • Cat Abnormal ultrasound finding (1) • Dog Abnormal stool colouration (1) • Dog Abnormal radiograph finding (1) • Cat Abnormal histology NOS (1) • Dog Abdominal pain (1) • Cat Abdominal discomfort (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Chihuahua, Female, 1.5 year, 3.583 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Leucocytosis NOS, Elevated bile acids, Overdose • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-075415
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 1.50 Year
  • Weight: 3.583 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Leucocytosis NOS Elevated bile acids Overdose
Outcomes: Ongoing

Cat, Domestic Shorthair, Female, 15 year, 3.302 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Elevated symmetrical dimethylarginine, Elevated creatinine, Elevated serum alkaline phosphatase, Weight loss, Accidental exposure… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-075358
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 15.00 Year
  • Weight: 3.302 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Elevated symmetrical dimethylarginine Elevated creatinine Elevated serum alkaline phosphatase Weight loss Accidental exposure Anaemia NOS
Outcomes: Ongoing

Cat, Domestic Shorthair, Male, 8 year, 6.35 kilogram • Drug: MSK, Oral, Dose: 250 Milligram per other, Frequency: 12 per hour • Reactions: Diarrhea • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-074759
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Male
  • Age: 8.00 Year
  • Weight: 6.350 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Dose: 250 Milligram per other
  • Frequency: 12 per hour
Reactions Reported:
Diarrhea
Outcomes: Outcome Unknown

Dog, Poodle - Standard, Female, 2 year, 20.412 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Death by euthanasia, Conjunctivitis, Ulceration NOS, Ear canal erythema, Welt… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-072787
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 2.00 Year
  • Weight: 20.412 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Death by euthanasia Conjunctivitis Ulceration NOS Ear canal erythema Welt Bumps on skin Skin inflammation NOS Loss of appetite Pain NOS Difficulty to rise Pyoderma Abnormal histology NOS Seizure NOS Neutropenia Monocytosis Elevated creatinine Thrombocytopenia Hyperkeratosis Itching
Outcomes: Euthanized

Cat, Domestic Mediumhair, Female, 2 year, 4.627 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Vomiting, Not eating, Hiding, Hyperglycaemia, Fever… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-072755
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 2.00 Year
  • Weight: 4.627 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Vomiting Not eating Hiding Hyperglycaemia Fever Tachycardia Tachypnoea Bloody stool Weight loss Gall bladder & bile duct disorder NOS Gastric distension Intestinal thickening Diarrhea
Outcomes: Ongoing

Cat, Domestic Shorthair, Female, 2.2 year, 4.2 kilogram • Drug: MSK, Unknown • Reactions: Not eating, Hiding, Fever, Vomiting, Low platelet count… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074690
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 2.20 Year
  • Weight: 4.200 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Not eating Hiding Fever Vomiting Low platelet count Platelet disorder NOS Hyperglycaemia Distress Hypothyroidism Other abnormal test result NOS Proteinuria Bilirubinuria Tarry or black stool Behavioral disorder (unspecified) Warm feeling to the touch Reddening of the skin Abnormal radiograph finding Distension of abdomen Pancreatitis NOS
Outcomes: Ongoing

Dog, Crossbred Canine/dog, Female, 12 year, 26.49 kilogram • Drug: MSK, Unknown • Reactions: Unwell, Not eating, Wound, Death, Necropsy performed • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-073819
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Female
  • Age: 12.00 Year
  • Weight: 26.490 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Unwell Not eating Wound Death Necropsy performed
Outcomes: Died

Dog, Shih Tzu, Female, 14 year, 6.35 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Malaise, Not himself/herself, Confusion, Sleepiness - systemic disorder, Arched back… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-072769
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 14.00 Year
  • Weight: 6.350 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Malaise Not himself/herself Confusion Sleepiness - systemic disorder Arched back Falling Collapse NOS Intervertebral disc disease Head down Paralysis Vocalisation Not defecating Pain NOS Head shake - behavioural disorder Rotatory nystagmus Death by euthanasia
Outcomes: Euthanized

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.